Theriva Biologics Inc (TOVX)
1.365
-0.06
(-3.87%)
USD |
NYAM |
Nov 14, 16:00
1.365
0.00 (0.00%)
After-Hours: 20:00
Theriva Biologics Free Cash Flow (Quarterly): -3.453M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -3.453M |
| March 31, 2024 | -4.881M |
| December 31, 2023 | -6.597M |
| September 30, 2023 | -3.082M |
| June 30, 2023 | -3.901M |
| March 31, 2023 | -5.618M |
| December 31, 2022 | -5.459M |
| September 30, 2022 | -4.467M |
| June 30, 2022 | -4.37M |
| March 31, 2022 | -4.902M |
| December 31, 2021 | -4.81M |
| September 30, 2021 | -2.156M |
| June 30, 2021 | -2.596M |
| March 31, 2021 | -3.342M |
| December 31, 2020 | -3.137M |
| September 30, 2020 | -2.054M |
| June 30, 2020 | -2.026M |
| March 31, 2020 | -4.96M |
| December 31, 2019 | -3.605M |
| September 30, 2019 | -3.062M |
| June 30, 2019 | -2.982M |
| March 31, 2019 | -4.224M |
| December 31, 2018 | -3.29M |
| September 30, 2018 | -3.602M |
| June 30, 2018 | -4.308M |
| Date | Value |
|---|---|
| March 31, 2018 | -6.079M |
| December 31, 2017 | -3.935M |
| September 30, 2017 | -4.722M |
| June 30, 2017 | -5.74M |
| March 31, 2017 | -6.019M |
| December 31, 2016 | -10.75M |
| September 30, 2016 | -6.137M |
| June 30, 2016 | -5.861M |
| March 31, 2016 | -5.718M |
| December 31, 2015 | -11.01M |
| September 30, 2015 | -15.61M |
| June 30, 2015 | -7.293M |
| March 31, 2015 | -5.476M |
| December 31, 2014 | -4.784M |
| September 30, 2014 | -4.557M |
| June 30, 2014 | -3.312M |
| March 31, 2014 | -3.474M |
| December 31, 2013 | -2.715M |
| September 30, 2013 | -1.732M |
| June 30, 2013 | -1.643M |
| March 31, 2013 | -1.665M |
| December 31, 2012 | -4.776M |
| September 30, 2012 | -1.449M |
| June 30, 2012 | -1.286M |
| March 31, 2012 | -1.415M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-6.597M
Minimum
Dec 2023
-2.026M
Maximum
Jun 2020
-3.969M
Average
-3.901M
Median
Jun 2023
Free Cash Flow (Quarterly) Benchmarks
| Merck & Co Inc | 8.508B |
| Pro-Dex Inc | 1.456M |
| BioCardia Inc | -1.315M |
| NovaBay Pharmaceuticals Inc | -0.58M |
| Palatin Technologies Inc | -6.477M |